Norman Roberts lissencephaly syndrome
Also Known As:
Lissencephaly 2; Lissencephaly syndrome, Norman-Roberts type
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Disease Context: Research Results
Related Diseases
Experts
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Norman Roberts lissencephaly syndrome:
1. | TeratogensIBA
12/01/2012
- " There were three patterns of abnormal cerebral lamination: (1) no normal laminar pattern before 28 weeks (n=32), in association with severe ventriculomegaly, diffuse ischemia, microcephaly, teratogen exposure or lissencephaly; (2) focal disruption of lamination before 28 weeks (n=24), associated with hemorrhage, porencephaly, stroke, migrational abnormalities, thanatophoric dysplasia, meningomyelocele or encephalocele; (3) increased prominence and echogenicity of the intermediate zone before 28 weeks and/or persistence of a laminar pattern beyond 33 weeks (n=10), associated with Type 1 lissencephaly or CMV infection. "
|
|